AntiVirals Inc. names vice president of regulatory affairs and clinical development.PORTLAND, Ore.--(BUSINESS WIRE)--March 4, 1997--AntiVirals Inc., a privately held biotechnology company engaged in the fields of gene-inactivating technology and drug delivery, Tuesday announced the appointment of Dr. Frederick C. Pearson to the new position of vice president of regulatory affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas: Pearson brings to AntiVirals more than 20 years experience in pharmaceutical and clinical research. He most recently served as director of biotechnology at the Colorado Advanced Technology Institute. His prior positions include vice president and general manager for Greenwich Pharmaceuticals Inc., vice president of product development for Virus Research Institute, vice president of scientific affairs for Cell Technology Inc. and eight years in management positions at Baxter. He received his Ph.D. in microbiology microbiology: see biology. microbiology Scientific study of microorganisms, a diverse group of simple life-forms including protozoans, algae, molds, bacteria, and viruses. and virology virology, study of viruses and their role in disease. Many viruses, such as animal RNA viruses and viruses that infect bacteria, or bacteriophages, have become useful laboratory tools in genetic studies and in work on the cellular metabolic control of gene expression from the University of New Hampshire New Hampshire, one of the New England states of the NE United States. It is bordered by Massachusetts (S), Vermont, with the Connecticut R. forming the boundary (W), the Canadian province of Quebec (NW), and Maine and a short strip of the Atlantic Ocean (E). . "We are pleased to welcome Dr. Pearson to our staff," said Denis Denis, king of Portugal: see Diniz. R. Burger, Ph.D., chief executive officer of AntiVirals. "His outstanding pharmaceutical, clinical and regulatory background will be an asset to AntiVirals as we move into the clinical and regulatory stages over the next two years." AntiVirals is an Oregon-based biotechnology company with corporate offices in Portland, and research facilities in Corvallis, Ore. The company is conducting pioneering research in the field of gene- inactivating technology, referred to as antisense antisense, DNA or RNA manipulated in a laboratory so that its components (nucleotides) form a complementary copy of normal, or "sense," messenger RNA (mRNA; see nucleic acid). , which may be useful in the treatment of a wide range of human disease. The company has also developed a new drug-delivery technology which may be useful with many FDA-approved drugs, as well as with antisense compounds. CONTACT: AntiVirals Inc., Portland Denis R. Burger, 503/227-0554 or Coffin Communications Group, Sherman Oaks, Calif. Doris Banchik, 818/789-0100 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion